Spok Corp (SPOK) Biznesning o‘zini qoplash muddati

USA Mobility - SPOK emitenti grafik logotipi

FCC va HIPAA tomonidan qat'iy nazorat AQSh klinik favqulodda aloqa nishasida yangi raqobatchilarning bozorga kirishini qiyinlashtiradi. Ushbu grafik 13.10 miqdoridagi P/E koeffitsientini aks ettiradi. Spok Holdings, Inc. (SPOK) shifoxonalar va huquqni muhofaza qilish organlari uchun bildirishnoma tizimlarini joriy qilish orqali xavflarni minimallashtiradi, pagerlarga bo'lgan talabning kamayishi esa zamonaviy Spok Mobile dasturiy ta'minotiga o'tish bilan samarali tarzda qoplanmoqda.

SPOK (Spok Corp) Narxning foydaga nisbati tarixi 04.07.2022dan 17.11.2026gacha

Spok Holdings, Inc. (SPOK) kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning jamlanma tahlili:Spok Holdings Inc - SPOK
USA Mobility asosiy tovari

Investor aktivlarning operatsion kuchini bozor kapitalizatsiyasining sof foydaga nisbati orqali baholaydi. Spok Holdings, Inc. (SPOK) kompaniyasining sog'liqni saqlash sohasidagi muhim aloqa tizimlaridagi monopol maqomi yuqori marja va barqaror pul oqimini ta'minlaydi. Kompaniyaning 13.10 miqdoridagi joriy P/E koeffitsiyentini tahlil qilib, biz investitsiyalarning qoplanish muddatini va bozorning biznesni haddan tashqari yuqori baholash darajasini aniqlaymiz. Past qiymatlar uning barqaror asosga ega bo'lgan ishonchli foyda generatori sifatidagi maqomini tasdiqlaydi.

Raqobatdosh kompaniyalar tahlili

Narx-foyda multiplikatori VEEV (Veeva Systems Inc)|P/E multiplikatori DOCS|HQY - Kapitalizatsiyaning foydaga nisbati|Waystar Health - Narx-foyda koeffitsiyenti|corvel.com (CRVL) - Kapitalizatsiyaning foydaga nisbati|Privia Health Group, Inc. - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati HURN (Huron Consulting Group Inc.)|CERT (Certara) - Narx-foyda koeffitsiyenti|OMCL - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati GoodRx Holdings, Inc.|Kapitalizatsiyaning foydaga nisbati Schrodinger, Inc. SDGR|P/E multiplikatori PHR|OMDA (Omada Health) - Kompaniya qiymatining sof foydaga nisbati|Evolent - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati HealthStream, Inc. (HSTM)|Definitive Healthcare Corp - P/E multiplikatori|CCSI - P/E multiplikatori|AGL: P/E multiplikatori|ABSI - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti SY|Kapitalizatsiyaning foydaga nisbati National Research Corp. NRC|Narx-foyda koeffitsiyenti OPRX (OptimizeRx Corporation)|Biznesning o‘zini qoplash muddati trubridge.com|Narxning foydaga nisbati Simulations Plus, Inc. SLP|Bozor narxining sof foydaga nisbati SOPH (SOPHiA GENETICS S.A.)|HCAT: Narx-foyda koeffitsiyenti|CareCloud Inc. (CCLD) - Narx-foyda koeffitsiyenti|RSSS (Research Solutions, Inc.) - Narx-foyda koeffitsiyenti|Narx-foyda koeffitsiyenti DLH Holdings Corp|Narxning foydaga nisbati OneMedNet Corp|Scienture Holdings (SCNX) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Healthcare Triangle (HCTI)|Biznesning o‘zini qoplash muddati iSpecimen Inc|P/E multiplikatori BFRG (bullfrogai.com)|Biznesning o‘zini qoplash muddati SCWorx (WORX)|MSPR - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati icoreconnect.com ICCT|TRxADE Health Corp (MEDS) - Narxning foydaga nisbati|ORGS - Biznesning o‘zini qoplash muddati|RCM - Kompaniya qiymatining sof foydaga nisbati|SHCR (Sharecare) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati Streamline Health (STRM)|P/E multiplikatori Syra Health (SYRA)|P/E multiplikatori AMEH (ApolloMed)|MODN: Narx-foyda multiplikatori|nextgen.com - P/E multiplikatori